Two European Labs Turn to Next-Gen Sequencing for BRCA1/2 Testing

While the University of Leeds Institute of Molecular Medicine at St. James's University Hospital performs diagnostic sequencing for the BRCA1, BRCA2, TP53, and other genes on the Illumina Genome Analyzer, the Center for Medical Genetics Ghent at Ghent University Hospital is currently evaluating the 454 platform for BRCA1 and BRCA2 testing.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.